Roghayyeh Baghban

2.4k total citations · 1 hit paper
22 papers, 1.7k citations indexed

About

Roghayyeh Baghban is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Roghayyeh Baghban has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biomedical Engineering. Recurrent topics in Roghayyeh Baghban's work include Ocular Surface and Contact Lens (3 papers), Advanced Drug Delivery Systems (3 papers) and Bacteriophages and microbial interactions (2 papers). Roghayyeh Baghban is often cited by papers focused on Ocular Surface and Contact Lens (3 papers), Advanced Drug Delivery Systems (3 papers) and Bacteriophages and microbial interactions (2 papers). Roghayyeh Baghban collaborates with scholars based in Iran, Poland and United States. Roghayyeh Baghban's co-authors include Rana Jahanban‐Esfahlan, Khaled Seidi, Abbas Ebrahimi‐Kalan, Saeed Kolahian, Mehdi Jaymand, Leila Roshangar, Tahereh Javaheri, Payman Zare, Safar Farajnia and Younes Ghasemi and has published in prestigious journals such as Applied Microbiology and Biotechnology, International Journal of Pharmaceutics and Journal of Cellular Physiology.

In The Last Decade

Roghayyeh Baghban

21 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor microenvironment complexity and therapeutic implications at a glance

2020 1.2k citations Roghayyeh Baghban, Leila Roshangar et al. Cell Communication and Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roghayyeh Baghban Iran	13	807	532	351	347	329	22	1.7k
Sritama Nath United States	13	1.1k 1.3×	802 1.5×	545 1.6×	362 1.0×	309 0.9×	22	2.0k
Juliana Hamzah Australia	21	736 0.9×	628 1.2×	281 0.8×	599 1.7×	258 0.8×	37	1.7k
Cian M. McCrudden United Kingdom	32	1.4k 1.8×	506 1.0×	279 0.8×	515 1.5×	235 0.7×	52	3.1k
Laura Conti Italy	31	961 1.2×	723 1.4×	268 0.8×	901 2.6×	396 1.2×	88	2.5k
Mohanraj Ramachandran Sweden	22	1.1k 1.3×	916 1.7×	266 0.8×	560 1.6×	468 1.4×	46	3.5k
Chun‐Wei Peng China	29	1.0k 1.3×	660 1.2×	396 1.1×	230 0.7×	525 1.6×	64	2.3k
Ern Yu Tan Singapore	24	916 1.1×	571 1.1×	207 0.6×	254 0.7×	682 2.1×	63	2.0k
Tahereh Javaheri Austria	16	1.1k 1.4×	780 1.5×	514 1.5×	434 1.3×	547 1.7×	22	2.4k
Lei Wei China	21	785 1.0×	274 0.5×	328 0.9×	465 1.3×	313 1.0×	67	2.0k
Xiaotu Ma United States	26	1.3k 1.6×	293 0.6×	720 2.1×	397 1.1×	382 1.2×	97	2.4k

Countries citing papers authored by Roghayyeh Baghban

Since Specialization

Citations

This map shows the geographic impact of Roghayyeh Baghban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roghayyeh Baghban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roghayyeh Baghban more than expected).

Fields of papers citing papers by Roghayyeh Baghban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roghayyeh Baghban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roghayyeh Baghban. The network helps show where Roghayyeh Baghban may publish in the future.

Co-authorship network of co-authors of Roghayyeh Baghban

This figure shows the co-authorship network connecting the top 25 collaborators of Roghayyeh Baghban. A scholar is included among the top collaborators of Roghayyeh Baghban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roghayyeh Baghban. Roghayyeh Baghban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baghban, Roghayyeh, et al.. (2025). Progressing nanotechnology to improve diagnosis and targeted therapy of Diabetic Retinopathy. Biomedicine & Pharmacotherapy. 183. 117786–117786. 2 indexed citations

Baghban, Roghayyeh, et al.. (2025). Implications of nanotechnology for the treatment of Dry Eye Disease: Recent advances. International Journal of Pharmaceutics. 672. 125355–125355.

Baghban, Roghayyeh, et al.. (2025). Advancing glaucoma treatment with nanotechnology: a new frontier in ophthalmology. International Journal of Pharmaceutics. 685. 126210–126210. 1 indexed citations

Baghban, Roghayyeh, Abdolmajid Ghasemian, & Shirin Mahmoodi. (2023). Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Archives of Microbiology. 205(4). 150–150. 18 indexed citations

Baghban, Roghayyeh, et al.. (2023). Recent advancements in nanomaterial-laden contact lenses for diagnosis and treatment of glaucoma, review and update. Journal of Nanobiotechnology. 21(1). 402–402. 18 indexed citations

Afarid, Mehrdad, Shirin Mahmoodi, & Roghayyeh Baghban. (2022). Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. Journal of Nanobiotechnology. 20(1). 361–361. 40 indexed citations

Rahimi, Mahdi, Seyed Mostafa Mir, Roghayyeh Baghban, et al.. (2022). Chitosan-based biomaterials for the treatment of bone disorders. International Journal of Biological Macromolecules. 215. 346–367. 46 indexed citations

Baghban, Roghayyeh & Shirin Mahmoodi. (2022). WITHDRAWN: Nucleic Acid-Based Vaccines Platform Against Covid-19Pandemic. Current Molecular Medicine. 22. 1 indexed citations

Baghban, Roghayyeh, Mehrdad Afarid, Jafar Soleymani, & Mahdi Rahimi. (2021). Were magnetic materials useful in cancer therapy?. Biomedicine & Pharmacotherapy. 144. 112321–112321. 23 indexed citations

10.

Baghban, Roghayyeh, et al.. (2021). Design and In Silico Evaluation of a Novel Cyclic Disulfide-Rich anti-VEGF Peptide as a Potential Antiangiogenic Drug. International Journal of Peptide Research and Therapeutics. 27(4). 2245–2256. 8 indexed citations

11.

Farajnia, Safar, et al.. (2020). Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease. BMC Research Notes. 13(1). 26–26. 16 indexed citations

12.

Baghban, Roghayyeh, Safar Farajnia, Younes Ghasemi, et al.. (2020). Mutational Analysis of Ocriplasmin to Reduce Proteolytic and Autolytic Activity in Pichia pastoris. Biological Procedures Online. 22(1). 25–25. 5 indexed citations

13.

Baghban, Roghayyeh, Leila Roshangar, Rana Jahanban‐Esfahlan, et al.. (2020). Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling. 18(1). 59–59. 1223 indexed citations breakdown →

14.

Farajnia, Safar, et al.. (2020). New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update. Anti-Cancer Agents in Medicinal Chemistry. 21(1). 3–19. 16 indexed citations

15.

Baghban, Roghayyeh, et al.. (2019). Structure Evaluation of IroN for Designing a Vaccine against Escherichia Coli, an In Silico Approach. 7(4). 93–106. 1 indexed citations

16.

Rahbarnia, Leila, et al.. (2019). Current trends in targeted therapy for drug-resistant infections. Applied Microbiology and Biotechnology. 103(20). 8301–8314. 12 indexed citations

17.

Baghban, Roghayyeh, et al.. (2019). CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond. Journal of Cellular Biochemistry. 120(10). 16379–16392. 10 indexed citations

18.

Baghban, Roghayyeh, Safar Farajnia, Younes Ghasemi, et al.. (2018). New Developments in Pichia pastoris Expression System, Review and Update. Current Pharmaceutical Biotechnology. 19(6). 451–467. 36 indexed citations

19.

Zarredar, Habib, et al.. (2018). Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro. Journal of Cellular Physiology. 234(2). 1560–1566. 30 indexed citations

20.

Baghban, Roghayyeh, Seyed Latif Mousavi Gargari, Masoumeh Rajabibazl, Javad Nazarian, & Hamid Bakherad. (2014). Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris. Biotechnology and Applied Biochemistry. 63(2). 200–205. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact